Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)

Hong Kong · Delayed Price · Currency is HKD

22.18

+0.20 (0.91%)

May 7, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Production and Sale of Biologics, Medical Hyaluronic Acid			2.63B	2.10B	1.75B	1.32B	1.60B
Production and Sale of Biologics, Medical Hyaluronic Acid Growth			25.27%	20.19%	32.14%	-16.99%	3.21%
Total			2.63B	2.10B	1.75B	1.32B	1.60B
Total Growth			25.27%	20.19%	32.14%	-16.99%	3.21%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mainland China			2.18B	1.70B	1.54B	1.17B	1.40B
Mainland China Growth			28.41%	10.14%	32.08%	-16.55%	1.35%
Europe			136.05M	140.81M	66.97M	-	-
Europe Growth			-3.38%	110.28%	-	-	-
United States of America (USA)			120.28M	103.72M	82.92M	62.53M	78.08M
United States of America (USA) Growth			15.97%	25.08%	32.62%	-19.92%	-4.08%
Other Regions and Countries			196.77M	159.83M	57.64M	83.72M	107.56M
Other Regions and Countries Growth			23.11%	177.28%	-31.15%	-22.17%	47.07%
United Kingdom (U.K.)			-	-	-	10.25M	10.33M
United Kingdom (U.K.) Growth			-	-	-	-0.85%	-0.33%
Total			2.63B	2.10B	1.75B	1.32B	1.60B
Total Growth			25.27%	20.19%	32.14%	-16.99%	3.21%

Source: S&P Global Market Intelligence.